2 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Baohui Han: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DREAM Study: DNA/RNA-NGS Co-Testing in Driver-Negative, Treatment-Resistant NSCLC This study did not include intervention between the two cohorts - Non-Small Cell Lung Cancer | Recruiting | Baohui Han | 508 | 2025-03-01 | 2025-02-26 | |
| Noninvasive Detection of Lung Nodule Malignancy Using cfDNA Fragmentomics This study did not include intervention between two cohorts - Lung Cancer (Diagnosis), Fragmentomics | Recruiting | Baohui Han | 240 | 2024-08-21 | 2026-02-10 | |
| Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy Adebrelimab, Irinotecan Liposome (II), Adebrelimab, Irinotecan Liposome (II), Famitinib - Extensive-stage Small-cell Lung Cancer | Phase 1 / Phase 2 | Not yet recruiting | Baohui Han | 80 | 2024-04-01 | 2024-03-27 |
| Aumolertinib Adjuvant Therapy of Resectable Stage I EGFRm+ NSCLC With High-grade Patterns Aumolertinib - Lung Cancer | Phase 2 | Unknown | Baohui Han | 104 | 2022-01-14 | 2023-04-21 |
| Combination of Chemotherapy and Gefitinib as First-line Treatment pemetrexed plus carboplatin, gefitinib - Non-Small-Cell Lung Cancer | Not applicable | Completed | Baohui Han | 121 | 2014-05-01 | 2016-04-20 |
| Erlotinib as Neoadjuvant Treatment in Patients With Stage ⅢA N2 NSCLC With Activating EGFR Mutation. erlotinib - Non Small Cell Lung Cancer | Phase 2 | Completed | Baohui Han | 25 | 2011-03-02 | 2017-09-12 |
Carcinoma, Non-Small-Cell Lung (3) · Lung Neoplasms (2) · Disease (1) · Small Cell Lung Carcinoma (1)
Carboplatin (1) · Erlotinib Hydrochloride (1) · Gefitinib (1) · Pemetrexed (1) · aumolertinib (1) · famitinib (1) · irinotecan sucrosofate (1)
China (6)
Aiqin Gu, Master (1) · Bo Jin, Dr (1) · Jun Pei (1) · Lei Zhu, Master (1) · Tianqing Chu, Dr (1) · Yanjie Niu, Master (1) · Yanwei Zhang, Dr (1)